Atlas Trials

Pulmotect, Inc.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Pulmotect, Inc.

RecordFirmDate
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV) (NCT06665100)Pulmotect, Inc.2025-06-27
A Multiple Ascending Dose Study of PUL-042 in Stem Cell Transplant Recipients (NCT03097796)Pulmotect, Inc.2024-12-01
The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection (NCT04312997)Pulmotect, Inc.2020-06-16
The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 (NCT04313023)Pulmotect, Inc.2020-06-09
The Effect of Inhaled PUL-042 on Rhinovirus-induced Symptoms in Smokers With GOLD Stage 0 COPD (NCT03794557)Pulmotect, Inc.2019-01-21

Track Pulmotect, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.